Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relation between mitral regurgitation and platelet activation

H F Tse1, C P Lau, G Cheng

  • 1Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.

Journal of the American College of Cardiology
|December 31, 1997
PubMed
Summary

Mitral regurgitation (MR) in mitral valve disease activates platelets, but mitral valve prolapse (MVP) alone does not. Platelet activation correlates with MR severity, suggesting a role in thromboembolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.

Journal of the American College of Cardiology·2018
Same author

2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population.

Hong Kong medical journal = Xianggang yi xue za zhi·2017
Same author

Effect of combined use of Fructus Schisandrae and statin on high-fat-diet-induced metabolic syndrome in rats.

Hong Kong medical journal = Xianggang yi xue za zhi·2016
Same author

Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2012
Same author

Subclinical atrial fibrillation and the risk of stroke.

The New England journal of medicine·2012
Same author

Efficacy and active components of herbal extracts on the treatment of tinea pedis.

Hong Kong medical journal = Xianggang yi xue za zhi·2011

Area of Science:

  • Cardiology
  • Hematology
  • Biomedical Science

Background:

  • Mitral valve prolapse (MVP) and rheumatic mitral regurgitation (MR) are linked to increased thromboembolic events.
  • The exact causes are unknown, but heightened platelet activation is a suspected pathogenic mechanism.
  • Previous studies on MVP and platelet activation yield conflicting results, and the association between MR and platelet activation in mitral valve disease remains unclear.

Purpose of the Study:

  • To investigate the impact of mitral regurgitation (MR) on platelet activation in patients with mitral valve prolapse (MVP) or rheumatic MR.
  • To determine if MVP itself is associated with increased platelet activation.
  • To explore the relationship between the severity of MR and the degree of platelet activation.

Main Methods:

Related Experiment Videos

  • Platelet activation was assessed by measuring plasma levels of platelet factor 4 (PF4) and beta-thromboglobulin (BTG).
  • The study included 16 patients with MVP, 12 with rheumatic MR, and 25 controls.
  • Echocardiography was used to evaluate the presence and severity of MR.

Main Results:

  • Patients with MVP and MR, and those with rheumatic MR, exhibited significantly higher plasma levels of PF4 and BTG compared to controls.
  • Platelet activation markers (PF4 and BTG) were positively correlated with the severity of MR.
  • MVP without MR was not associated with increased platelet activation compared to controls.

Conclusions:

  • Mitral regurgitation (MR) in mitral valve disease is linked to systemic platelet activation.
  • Mitral valve prolapse (MVP) in the absence of significant MR is not associated with heightened platelet activation.
  • The degree of platelet activation correlates with MR severity and is independent of disease etiology, age, or left atrial size, warranting further investigation into thromboembolic risk and antiplatelet therapy.